You are invited to join

Drug Hunter Flashtalks

·

Registration

This is a multi-session event. Please select how you would like to join.
Wed, Jun 29
4:00 PM

Event Information

​The Drug Hunter Speaker Series is an ongoing series of talks about drug discovery with the Drug Hunter team and guest experts in the field.

​Each virtual event will have a presentation, interview, or conversation with guests, followed by audience Q&A and discussion.

Watch previous sessions on our Drug Hunter YouTube channel.


​Our Upcoming Sessions:

Flash Talk with Kate Jackson — June 29, 12pm EST

Topic: the discovery and characterization of CFT8634, a potent and selective degrader of BRD9 for the treatment of SMARCB1-perturbed cancers

Kate did her undergrad work at Boston College and earned her PhD from the University of Colorado at Boulder, where she worked on complex natural product synthesis, culminating in a total synthesis of norhalicondrin B.  After her graduate studies, she completed her postdoctoral work at Harvard University with Professor Yoshito Kishi, investigating the total synthesis and biological evaluation of mycolactone natural products.

Following her graduate work, Kate joined the medicinal chemistry team at Vertex Pharmaceuticals where she contributed to programs in virology, oncology, and adrenoleukodystrophy.  Since 2018, Kate has been on the Chemistry Leadership Team at C4 Therapeutics, where she is leads multiple projects and enjoys working alongside her colleagues to deliver on the promise of targeted protein degradation.


Our Host(s):

Dr. Dennis Hu, CEO and Editor-in-Chief for Drug Hunter

Dennis started Drug Hunter because he felt science-focused drug discovery professionals were underserved by existing media outlets. Dennis started his career as a drug discovery scientist at a now publicly-listed biotech startup (RAPT), where he contributed to the discovery of a first-in-class phase II drug candidate for cancer immunotherapy which demonstrated efficacy in early patients. He later joined Genentech, a subsidiary of Roche, the largest pharmaceutical company in the world by revenue. He has been a chemistry and project team leader for several projects leading to patented and published chemical matter. He earned his PhD in Chemistry from Stanford University, MPhil by Research from the University of Cambridge on a Churchill Scholarship, and a dual BA/MS from Northwestern University as a Goldwater Scholar.


About Drug Hunter

Drug Hunter helps drug discovery professionals save time, stay up-to-date, and discover ideas by curating factual information and providing a platform for industry experts to share knowledge. Our goal is to provide an inclusive platform that empowers, educates, and connects professional drug hunters, and celebrates the important work being done by the heroes in our industry.